Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
33 studies found for:    " November 12, 2008":" December 12, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Completed Seroprevalence of HSV-2 in HIV Infected Subjects and the Effect of Daily Valacyclovir in the Reduction of HSV-2 Recurrence and Viral Shedding
Conditions: HSV-2;   HIV;   HIV Infections
Interventions: Drug: Valacyclovir;   Drug: Placebo
2 Completed Impact of Different Contraceptives on the Immune System of HIV Infected Women in Zambia
Conditions: HIV;   Contraception;   HIV Infections
Interventions: Drug: Depo Provera;   Device: Copper T Intrauterine contraception device
3 Unknown  Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus
Conditions: Dry Eye Syndromes;   HIV Seropositivity
Interventions: Drug: cyclosporine and sodium carboximethycellulose;   Drug: sodium carboximethycellulose
4 Completed Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1
Conditions: HIV-1;   HIV Infections
Intervention: Drug: Raltegravir
5 Completed
Has Results
Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial
Conditions: Cardiovascular Disease;   HIV Infection
Interventions: Drug: Lovaza;   Drug: Placebo
6 Completed Mupirocin Ointment to Eliminate Nasal Carriage of Staphylococcus Aureus in HIV Infection
Conditions: Staphylococcus Aureus;   HIV Infections
Interventions: Drug: Mupirocin calcium ointment, 2%;   Drug: Placebo ointment
7 Completed Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector
Condition: HIV Infections
Interventions: Biological: DNA Vaccine;   Biological: DNA Vaccine placebo;   Biological: rAd35;   Biological: rAd35 placebo;   Biological: rAd5;   Biological: rAd5 placebo
8 Active, not recruiting Micronutrients and Antioxidants in HIV Infection
Condition: HIV Infection
Interventions: Dietary Supplement: Micronutrients and antioxidants;   Dietary Supplement: Multivitamins and minerals
9 Completed Efficacy of Treatment Intensification With Maraviroc on HIV-1 Viral Latency in Recently Infected Hiv-1 naïve Patients Starting Raltegravir Plus Tenofovir/Emtricitabine
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Maraviroc;   Drug: Tenofovir/Emtricitabine
10 Recruiting Antiretroviral Therapy for Acute HIV Infection
Condition: Acute HIV Infection
Interventions: Drug: HAART;   Drug: Mega-HAART
11 Unknown  Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia
Conditions: HIV Infection;   Hemophilia A
12 Completed Examination of B Cell Responses in Human Blood
Condition: HIV Infections
13 Completed Cognitive Behavioral Treatment to Reduce Alcohol Use Among HIV-Infected Kenyans
Conditions: Binge Drinking;   Alcohol Abuse;   Alcohol Dependence;   HIV Infections
Interventions: Behavioral: HIV support group;   Behavioral: CBT
14 Completed Efficacy And Security Of Annual And Biennial Zoledronic Acid For Osteoporosis Treatment In An HIV-Infected Patients' Cohort
Condition: HIV Infections
Interventions: Drug: Zoledronic acid;   Behavioral: Lifestyle modifications
15 Active, not recruiting
Has Results
An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children
Condition: Human Immunodeficiency Virus (HIV)
Intervention: Drug: Maraviroc
16 Completed A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults
Conditions: Human Immunodeficiency Virus;   Human Papillomavirus- 6, 11, 16, 18;   Adolescent;   Papillomavirus Vaccines
Interventions: Biological: Gardisil;   Behavioral: Survey
17 Completed A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL
Conditions: Lymphoma, AIDS Related;   HIV Infections
Intervention: Drug: R-EPOCH and cART
18 Recruiting Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population
Condition: Acute HIV Infection
19 Completed Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Efavirenz (EFV);   Drug: Rifampin-containing anti-TB therapy
20 Completed Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial)
Condition: HIV
Intervention: Biological: Dendritic Cell Vaccine

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Indicates status has not been verified in more than two years